View all news

    Janssen Receives Two U.S. FDA Approvals for Simponi aria® (Golimumab) for the Treatment of Adults with Active Psoriatic Arthritis or Active Ankylosing Spondylitis

    10/20/2017
    Download(opens in new window)PDF 8 KB
    Janssen Receives Two U.S. FDA Approvals for Simponi aria® (Golimumab) for the Treatment of Adults with Active Psoriatic Arthritis or Active Ankylosing Spondylitis

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com